LBA40_PRARIEL3: A Phase 3, Randomised, Double-Blind Study of Rucaparib vs Placebo Following Response to Platinum-Based Chemotherapy for Recurrent Ovarian Carcinoma (OC)
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx440.034
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2017
Authors
Publisher
Elsevier BV